US Tech Stocks Sink as Chinas DeepSeek Triggers Broad AI Infrastructure Selloff Global Infrastructure Funding Doubles in Five Years Driven by Japanese Bank Lending Toll Brothers Unveils New Amenities at Cross Kirkland Towns Community Marvell Dell Earnings and Feds Inflation Gauge Set the Tone for the Trading Week Luhansk Strike Escalates Geopolitical Risk Market Implications of RussiaUkraine Tensions Amgen Releases First Quarter 2026 Earnings Report Key Highlights ONON Q1 2026 Earnings EPS Smashes Estimates with 5146 Surprise Shares Edge Higher GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline Quantum Corporation QMCO Q1 2026 Earnings EPS Surpasses Expectations Amid Ongoing Restructuring IPAR Q1 2026 Earnings Strong EPS Beat Highlights Robust Fragrance Demand Amid Market Challenges PEW Q1 2026 Earnings NarrowerThanExpected Loss Fails to Boost Sentiment JNJ Shows Resilient Rise Johnson Johnson Edges Higher Amid Defensive Appeal KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure Four Seasons Education FEDU Falls Sharply as Stock Tests Key Support at 960 Roku Inc ROKU Holds Steady Near Support Is a Breakout Imminent Gevo Inc GEVO Edges Higher as Shares Test Key Resistance Levels Fed Rate Cut Prospects Dim as Jobs Data Signals Sticky Inflation STLA Q1 2026 Earnings EPS Misses Estimates Amid Industry Headwinds Alliance Laundry Holdings ALH Edges Higher Testing Key Resistance Level Lixte Biotechnology Holdings LIXT Faces Selling Pressure as Shares Dip 34 Insight Digital Partners II Units DYORU Hovers Near Support Amid Modest Decline Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued Stellus Capital Investment Corporation SCM Edges Lower Amid Sector Headwinds Classover Holdings KIDZ Jumps 8 as Stock Approaches Critical Resistance at 051 Trident Digital Tech Holdings TDTH Surges Over 8 Key Levels in Focus Kiora Pharmaceuticals KPRX Slips 45 as Stock Tests Key Support Level